UNSPSC 51323102: Axitirome

This classification denotes an anti-lipidemic agent with the molecular formula C25H24FNO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V477CK910J, chemically known as ethyl ( -)-((4-(3-((4-fluorophenyl)hydroxymethyl)-4-hydroxyphenoxy)-3,5-dimethylphenyl)amino)oxoacetate but generally known as axitirome, which bears US NIH Compound Identifier 166559. The term AXITIROME is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 3, 2000, List 44).

Most nations schedule axitirome under HS 29242995 and SITC 51479. As of Q4 2014, AXITIROME remains the US FDA Preferred Term for this commodity. Axitirome bears US NLM identifiers UMLS ID C2698282 and NCI Concept Code C75992. SMILES: CCOC(=O)C(=O)NC1=CC(=C(C(=C1)C)OC2=CC(=C(C=C2)O)C(C3=CC=C(C=C3)F)O)C.

UNSPSC 51323102 Axitirome is a Commodity code covering emergency pharmaceutical products, including injectable medications used in acute care and prehospital settings. State and local governments currently procure under this code specific formulations of advanced life support medications—epinephrine, adenosine, labetalol, and diltiazem—supplied to fire rescue departments, hospital systems, and emergency medical services. The code also encompasses broader pharmaceutical supply agreements where state health agencies and multistate cooperative purchasing vehicles source generic and branded medications through wholesaler networks. Issuing bodies include municipal purchasing departments (city fire rescue), state health and human services agencies, and cooperative purchasing alliances administered by state procurement offices on behalf of multiple member jurisdictions.

Recent activity centers in Florida and Minnesota, with statewide programs in Texas. The City of Tampa's Purchasing Department solicited sealed bids (RFQ 26P00188, due April 8, 2026) for four advanced life support medication line items—370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials—for Tampa Fire Rescue, with an estimated contract value of $40,000 and a one-year initial term plus renewal options. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP (S1070000015802, due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota and Oregon, requiring suppliers to work through three authorized wholesalers with cGMP and DSCSA compliance. The Texas Health and Human Services Commission posted an RFI (HHS0017013, April 3, 2026) exploring direct-to-manufacturer prescription programs outside traditional PBM and wholesaler channels. Small and local business enterprise set-asides appear in municipal solicitations; cooperative purchasing vehicles emphasize price competitiveness and wholesaler integration.